Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. anxiety insomnia depression
Show results for
Products
Services
Software
Training
Applications

Companies

News
Articles
Books
Magazines
Downloads
Videos

Refine by
Date

  • Older

Anxiety Insomnia Depression Articles & Analysis

39 news found

With two in five employees undergoing fertility treatment leaving their jobs or considering quitting, are companies doing enough?

With two in five employees undergoing fertility treatment leaving their jobs or considering quitting, are companies doing enough?

An international survey from Ferring, Fertility Matters at Work and This Can Happen reveals a significant gap exists between employees and employers in recognising the experience of undergoing fertility treatment1 Nearly all employees say fertility treatment impacts their mental health, yet only one third feel supported by their employer’s fertility policies1 Around the world, ...

ByFerring Pharmaceuticals


Unlock Functional Ingredient Benefits: Lecithin, Omega Fatty Acids, Phytosterol, Antioxidants at Alfa Chemistry

Unlock Functional Ingredient Benefits: Lecithin, Omega Fatty Acids, Phytosterol, Antioxidants at Alfa Chemistry

Over the past decade, Alfa Chemistry has shown abundant expertise in the rapidly growing dietary supplements sector. To cater to the rising demand in this field, the company decided to add lecithin, omega fatty acids, phytosterol, and antioxidants to its already versatile functional ingredient offerings. Fully aware of the importance of lecithin in the dietary supplements industry, Alfa Chemistry ...

ByAlfa Chemistry


Ace Therapeutics Unveils Model Development Services to Power Up Psychiatric Drug R&D

Ace Therapeutics Unveils Model Development Services to Power Up Psychiatric Drug R&D

Ace Therapeutics, a preclinical contract research organization (CRO) actively engaged in mental illness research, has announced the launch of its model development services, which aim to revolutionize psychiatric drug research and development. Psychiatric drug development is a crucial aspect of mental health treatment, as it involves the development of medications that can effectively treat ...

ByAce Therapeutics


CanaQuest Announces Key Appointments to Team to Drive CQ-001 through Clinical Trials

CanaQuest Announces Key Appointments to Team to Drive CQ-001 through Clinical Trials

CanaQuest Medical Corp (“CanaQuest” or the “Company”) (OTC: CANQF), is pleased to announce strategic additions to its executive team with expertise in conducting clinical trials and US FDA drug approval success. The team plans to effectively navigate the regulatory approval process for Drug Candidate, CQ-001 (cannabidiol + proprietary API composition), to treat rare ...

ByCanaQuest Medical Corp.


Dreams and Sleep Quality:  Finding the Best Anti-Snoring Device

Dreams and Sleep Quality: Finding the Best Anti-Snoring Device

Are you restless during sleep at night? Do you often wake up at night due to bad dreams or have difficulty in falling asleep? Are you anxious before you sleep? There are a variety of issues that can hamper proper and restful sleep at night, apart from snoring. According to University of Arizona clinical professor of medicine and dream specialist, Rubin Naiman, PhD, the two key components of good ...

ByTannerMedico A/S - Asonor


MedSource Corporate Wellness Tips: Create A Culture of Gratitude With Your Team

MedSource Corporate Wellness Tips: Create A Culture of Gratitude With Your Team

Thanksgiving is a time when families gather around the table to give thanks for their blessings, share a delicious meal, and create memories. It’s a holiday that encourages us to reflect on what we are grateful for and appreciate the people and opportunities in our lives. While Thanksgiving is traditionally a family-centric holiday, it’s also an excellent opportunity for businesses to ...

ByMedsource Labs


NHL Alumni Association partners with CanaQuest and NEEKA Health to Conduct Studies for Anxiety and Quality of Life in former NHL Players

NHL Alumni Association partners with CanaQuest and NEEKA Health to Conduct Studies for Anxiety and Quality of Life in former NHL Players

NHL Alumni Association (NHLAA), NEEKA Health Canada("NEEKA"),and CanaQuest Medical Corp ("CanaQuest") are pleased to announce a transformative study partnership that will investigate the efficacy of Mentanine® as a potential treatment to reduce anxiety in former NHL ...

ByCanaQuest Medical Corp.


Animal Emotional Behavior Tests for Anxiety and Depression Treatment

Animal Emotional Behavior Tests for Anxiety and Depression Treatment

In today’s fast-paced and stressful society, the prevalence of anxiety and depression has become a significant concern. Emotion-related animal behavior tests aim to provide a good research tool for the study of emotion-associated diseases. Anxiety and depression affect millions of individuals worldwide, leading to a significant burden on public health and impacting overall quality of ...

ByProtheragen


CANAQUEST Announces Award of European Cannabinoid Patent

CANAQUEST Announces Award of European Cannabinoid Patent

We believe we can provide a safer alternative to other THC products providing the benefits without the negative psychiatric side effects. Pre-clinical trials have demonstrated the reversal of depression-like and schizophrenia-related symptoms, blockage of memory impairment, hyperactive activity, and gene vulnerability. CanaQuest Medical Corp ("CanaQuest" or the "Company") (OTC:CANQF), a ...

ByCanaQuest Medical Corp.


CanaQuest Awarded Best Global Medical Cannabinoid Development Company 2023 by UK-based Global Health & Pharma for their 8th Annual Healthcare and Pharmaceutical Program

CanaQuest Awarded Best Global Medical Cannabinoid Development Company 2023 by UK-based Global Health & Pharma for their 8th Annual Healthcare and Pharmaceutical Program

Canaquest Medical Corp (OTC PINK:CANQF) (the "Company" or "CanaQuest"), a clinical-stage life sciences company focused on drug discovery and development of next-generation targeted cannabinoid therapeutics for the central nervous system (CNS), today announced that it has been awarded the Best Global Medical Cannabinoid Development Company 2023, in its eighth annual Healthcare and Pharmaceutical ...

ByCanaQuest Medical Corp.


CanaQuest and Neeka Health Sign Agreement to Conduct Clinical Studies with Mentanine

CanaQuest and Neeka Health Sign Agreement to Conduct Clinical Studies with Mentanine

Canaquest Medical Corp (OTC:CANQF) (the "Company" or "CanaQuest"), a clinical-stage life sciences company focused on drug discovery and development of next-generation targeted cannabinoid therapeutics for the central nervous system (CNS), today announced the signing of a Master Service Agreement with Neeka Health (“Neeka”) that will encompass multiple clinical studies to evaluate the ...

ByCanaQuest Medical Corp.


CanaQuest Launches Mentanine (R) (Cannabidiol + IP Formula) in the US via www.canaqueststore.com, Supported by Western University Pre-Clinical Trials Targeting Anxiety, Depression and PTSD

CanaQuest Launches Mentanine (R) (Cannabidiol + IP Formula) in the US via www.canaqueststore.com, Supported by Western University Pre-Clinical Trials Targeting Anxiety, Depression and PTSD

Canaquest Medical Corp (OTC Pink:CANQF) (the "Company" or "CanaQuest"), an award-winning, Clinical Stage/Life-Sciences company focused on drug discovery and development of next-generation targeted therapeutics within the endocannabinoid system and specific brain receptors, today announced its US launch of all-natural Mentanine® (cannabidiol "CBD" + IP, Omega-3s, DHA, EPA formula) in ...

ByCanaQuest Medical Corp.


Canaquest Launches Mentanine (Cannabidiol + IP Formula) in the US via www.canaqueststore.com, Supported by Western University Pre-Clinical Trials Targeting Anxiety, Depression and PTSD

Canaquest Launches Mentanine (Cannabidiol + IP Formula) in the US via www.canaqueststore.com, Supported by Western University Pre-Clinical Trials Targeting Anxiety, Depression and PTSD

Canaquest Medical Corp (OTC PINK:CANQF) (the “Company” or “CanaQuest“), an award-winning, Clinical Stage/Life-Sciences company focused on drug discovery and development of next-generation targeted therapeutics within the endocannabinoid system and specific brain receptors, today announced its US launch of all-natural Mentanine (cannabidiol “CBD” + IP, Omega-3s, ...

ByCanaQuest Medical Corp.


VeriSIM Life and Total Brain Announce Strategic Collaboration Agreement Applying AI to Develop New Drugs for Neurological Disorders

VeriSIM Life and Total Brain Announce Strategic Collaboration Agreement Applying AI to Develop New Drugs for Neurological Disorders

VeriSIM Life (VeriSIM), the leading artificial intelligence (AI)-enabled, unique R&D decisions de-risker for breakthrough drug development, today announced that it has entered into a partnership agreement with Total Brain, an applied, integrative neuroscience company, to create breakthrough neurodata-driven actionable insights for developing novel drugs to treat a wide range of neurological ...

ByVeriSIM Life


Neopharmed Gentili acquires Lormetazepam product portfolio to strengthen its neurology division

Neopharmed Gentili acquires Lormetazepam product portfolio to strengthen its neurology division

The transaction allows Neopharmed Gentili to strengthen its portfolio in the neuro-psychiatric area with high value-added drugs for the treatment of insomnia. Neopharmed Gentili, an Italian pharmaceutical company controlled by Ardian in partnership with the Del Bono family, which has historic roots in its territory and is pursuing international growth, announced that it has ...

ByNeopharmed Gentili S.p.A.


Virtual Reality is being used in exciting ways to treat anxiety and depression

Virtual Reality is being used in exciting ways to treat anxiety and depression

According to a Mashable article on a study of the efficacy of VR treatment for depression and anxiety, “This type of immersive therapy is a viable and potentially revolutionizing method to treat certain mental health conditions. A blend of VRET and well–established practices in mental health treatment can both augment and enhance other forms of therapy, the research suggests. For ...

Byni2o, Inc.


Lt. Governor Rutherford Leads Maryland Delegation to MEDICA 2021 Trade Show in Germany

Lt. Governor Rutherford Leads Maryland Delegation to MEDICA 2021 Trade Show in Germany

Medical forum attracts thousands of exhibitors from more than 50 countries across the globe BALTIMORE, MD (November 16, 2021) — Lt. Governor Boyd K. Rutherford is leading a delegation of 10 Maryland companies this week to MEDICA 2021, the world’s largest medical trade show in Dusseldorf, Germany, which typically attracts more than 120,000 attendees from around the world. This is the ...

BySpiraLith Brand of Micropore, Inc.


Accenture HealthTech Innovation Challenge Names Eight Finalists

Accenture HealthTech Innovation Challenge Names Eight Finalists

Accenture (NYSE: ACN) has named eight companies as finalists in the Accenture HealthTech Innovation Challenge, which brings together leading-edge startups with prominent health companies to tackle some of North America’s greatest health challenges. Attracting more than 2,600 startup applicants in the past five years, the Accenture HealthTech Innovation Challenge supports finding innovative ...

ByDonisi Health


CanaQuest Files International Mentanine(R) Patent, a Scientific CBD Formulation for Mental Health

CanaQuest Files International Mentanine(R) Patent, a Scientific CBD Formulation for Mental Health

Canaquest Medical Corp (OTC PINK:CANQF) (the “Company” or “CanaQuest“), an award-winning Life Science/Pharmaceutical company developing formulations combining cannabinoid molecules with pharmaceutical-grade botanical compounds, today announced the filing of its International Patent, trade named Mentanine, which has demonstrated at least 10-times (10X) the efficacy compared ...

ByCanaQuest Medical Corp.


Q&A with Dr. Carina Carnlöf, lead investigator of the RedHeart study

Q&A with Dr. Carina Carnlöf, lead investigator of the RedHeart study

In the recently published RedHeart Study the Coala Heart Monitor was used to remotely monitor 821 women with palpitation issues for 60 days. Over 200,000 individual ECG strips were analyzed. The direct ECG response of the Coala Heart Monitor contributed to reduced levels of anxiety, depression and symptoms of palpitations. The direct ECG response of the Coala also led to an increased quality of ...

ByCoala Life Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT